{"id":"https://openalex.org/W43866625","doi":null,"title":"Impact of atorvastatin plus n-3 PUFA on metabolic, inflammatory and coagulative parameters in metabolic syndrome without and with type 2 diabetes mellitus","display_name":"Impact of atorvastatin plus n-3 PUFA on metabolic, inflammatory and coagulative parameters in metabolic syndrome without and with type 2 diabetes mellitus","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W43866625","mag":"43866625"},"language":"en","primary_location":{"id":"pmh:oai:iris.unipa.it:10447/49495","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10447/49495","pdf_url":null,"source":{"id":"https://openalex.org/S4306401065","display_name":"Nova Science Publishers (Nova Science Publishers, Inc.)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059173192","display_name":"Giuseppe Avellone","orcid":"https://orcid.org/0000-0002-4539-6059","observed_orcids":["https://orcid.org/0000-0002-4539-6059"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppe Avellone","raw_affiliation_strings":["Biomedico di Medicina Interna e Specialistica"],"raw_orcid":"https://orcid.org/0000-0002-4539-6059","affiliations":[{"raw_affiliation_string":"Biomedico di Medicina Interna e Specialistica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051383358","display_name":"Valentina Guarnotta","orcid":"https://orcid.org/0000-0002-8088-4947","observed_orcids":["https://orcid.org/0000-0002-8088-4947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentina Guarnotta","raw_affiliation_strings":["Biomedico di Medicina Interna e Specialistica"],"raw_orcid":"https://orcid.org/0000-0002-8088-4947","affiliations":[{"raw_affiliation_string":"Biomedico di Medicina Interna e Specialistica","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005714507","display_name":"Vincenzo Di Garbo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincenzo Di Garbo","raw_affiliation_strings":["Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D\u2019Alessandro\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D\u2019Alessandro\u201d","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112300828","display_name":"Giovanni Abruzzese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Abruzzese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Domenico Campisi","orcid":"https://orcid.org/0000-0002-3785-9973","observed_orcids":["https://orcid.org/0000-0002-3785-9973"]},"institutions":[{"id":"https://openalex.org/I900890020","display_name":"University of Palermo","ror":"https://ror.org/044k9ta02","country_code":"IT","type":"education","lineage":["https://openalex.org/I900890020"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Domenico Campisi","raw_affiliation_strings":["Universit\u00e0 Degli Studi di Palermo"],"raw_orcid":"https://orcid.org/0000-0002-3785-9973","affiliations":[{"raw_affiliation_string":"Universit\u00e0 Degli Studi di Palermo","institution_ids":["https://openalex.org/I900890020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030692604","display_name":"Antonio Ventura Pinto","orcid":"https://orcid.org/0000-0002-8083-3699","observed_orcids":["https://orcid.org/0000-0002-8083-3699"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ant\u00f3nio Pinto","raw_affiliation_strings":["Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D\u2019Alessandro\u201d"],"raw_orcid":"https://orcid.org/0000-0002-8083-3699","affiliations":[{"raw_affiliation_string":"Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D\u2019Alessandro\u201d","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009811578","display_name":"Giuseppe Pizzo","orcid":"https://orcid.org/0000-0001-8119-4924","observed_orcids":["https://orcid.org/0000-0001-8119-4924"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppe Pizzo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8119-4924","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5107840616","display_name":"Giuseppe Licata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppe Licata","raw_affiliation_strings":["Biomedico di Medicina Interna e Specialistica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedico di Medicina Interna e Specialistica","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.00815454,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"2","issue":"1","first_page":"181","last_page":"192"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.8720999956130981,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.8720999956130981,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.12319999933242798,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.9779999852180481},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.9919999837875366},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.7260000109672546},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.8960000276565552},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8849999904632568},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9909999966621399},{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.8040000200271606},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":0.8320000171661377},{"id":"https://openalex.org/keywords/factor-vii","display_name":"factor VII","score":0.6729999780654907},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9210000038146973},{"id":"https://openalex.org/keywords/blood-viscosity","display_name":"blood viscosity","score":0.8730000257492065},{"id":"https://openalex.org/keywords/plasma-viscosity","display_name":"plasma viscosity","score":0.9629999995231628},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.8999999761581421},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7581979632377625},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.7444967031478882},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.7370648384094238},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7343072891235352},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6045705676078796},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5516083836555481},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4916089177131653},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4719730317592621},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.45772585272789},{"id":"https://openalex.org/C19038510","wikidata":"https://www.wikidata.org/wiki/Q2005087","display_name":"Polyunsaturated fatty acid","level":3,"score":0.4476562440395355},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.12115448713302612},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10813018679618835},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0687200129032135}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:iris.unipa.it:10447/49495","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10447/49495","pdf_url":null,"source":{"id":"https://openalex.org/S4306401065","display_name":"Nova Science Publishers (Nova Science Publishers, Inc.)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:43866625","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Vincenzo_Di_Garbo/publication/233858489_Impact_of_atorvastatin_plus_n-3_PUFA_on_metabolic_inflammatory_and_coagulative_parameters_in_metabolic_syndrome_without_and_with_type_2_diabetes_mellitus/links/09e4150c3bd717a6d0000000.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W50822124","https://openalex.org/W168736319","https://openalex.org/W207237111","https://openalex.org/W1825869055","https://openalex.org/W1860278769","https://openalex.org/W1946355373","https://openalex.org/W1965806496","https://openalex.org/W1968144530","https://openalex.org/W1969927159","https://openalex.org/W1975459220","https://openalex.org/W1988689746","https://openalex.org/W1998747783","https://openalex.org/W2002240714","https://openalex.org/W2002337281","https://openalex.org/W2007499677","https://openalex.org/W2007542782","https://openalex.org/W2014226775","https://openalex.org/W2022104584","https://openalex.org/W2023555072","https://openalex.org/W2031831221","https://openalex.org/W2032485049","https://openalex.org/W2035440468","https://openalex.org/W2048722271","https://openalex.org/W2054332925","https://openalex.org/W2055191929","https://openalex.org/W2057674977","https://openalex.org/W2058610272","https://openalex.org/W2059537042","https://openalex.org/W2059908741","https://openalex.org/W2060027313","https://openalex.org/W2060709766","https://openalex.org/W2061489988","https://openalex.org/W2061755142","https://openalex.org/W2076118051","https://openalex.org/W2077760013","https://openalex.org/W2087878463","https://openalex.org/W2087949182","https://openalex.org/W2089286420","https://openalex.org/W2106343349","https://openalex.org/W2114369438","https://openalex.org/W2119236594","https://openalex.org/W2120549911","https://openalex.org/W2122426884","https://openalex.org/W2122656413","https://openalex.org/W2123289485","https://openalex.org/W2123420731","https://openalex.org/W2127360512","https://openalex.org/W2131600514","https://openalex.org/W2135212903","https://openalex.org/W2139176866","https://openalex.org/W2139673272","https://openalex.org/W2142347023","https://openalex.org/W2143431760","https://openalex.org/W2152316341","https://openalex.org/W2167075471","https://openalex.org/W2170594848","https://openalex.org/W2192223169","https://openalex.org/W2321718841","https://openalex.org/W2402257898","https://openalex.org/W2407150778","https://openalex.org/W2477872031","https://openalex.org/W2750405842","https://openalex.org/W4244383122","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W2606036714","https://openalex.org/W2164928189","https://openalex.org/W1899233879","https://openalex.org/W2736714017","https://openalex.org/W6977249519","https://openalex.org/W2981657491","https://openalex.org/W2761910533","https://openalex.org/W1802119609","https://openalex.org/W2410027436","https://openalex.org/W2181485349"],"abstract_inverted_index":{"Aim":[0],"High":[1],"serum":[2],"levels":[3,13,240],"of":[4,14,22,58,68,115,126,136,291,296,301],"low-density":[5,175],"lipoprotein":[6,176,181],"cholesterol":[7,177,182,185],"(LDL-C),":[8,178],"triglycerides":[9,203],"(TG)":[10],"and":[11,25,47,83,91,105,118,143,160,187,205,211,236,273,287,289,303],"low":[12],"high-densitycholesterol":[15],"(HDL)":[16],"are":[17],"associated":[18],"to":[19,26,73,111,158,167,242,314],"elevated":[20],"incidence":[21],"cardiovascular":[23,59,320],"events":[24],"sudden":[27],"death.":[28],"This":[29,61],"lipidic":[30,79,297],"pattern":[31],"is":[32,312],"often":[33],"observed":[34,215],"in":[35,86,98,148,174,228,318],"patients":[36,42,87,96,140,270],"with":[37,43,88,92,101,141,144,196,260,271,277,293],"visceral":[38],"obesity":[39],"such":[40],"as":[41,194],"Metabolic":[44],"Syndrome":[45],"(MS)":[46],"Type":[48],"2":[49],"Diabetes":[50],"Mellitus":[51],"(T2DM)":[52],"which":[53],"have":[54,315],"an":[55,133,308],"increased":[56],"risk":[57],"events.":[60],"open-label,":[62],"cross-over":[63],"study":[64,100,122,128],"evaluated":[65],"the":[66,127],"efficacy":[67],"n-3":[69,280],"PUFA":[70,281],"(3g/die)":[71],"added":[72],"atorvastatin":[74,137],"(20":[75],"mg)":[76],"(ATV)":[77],"on":[78,81,202,209,250,264,285],"profile,":[80],"haemorherologic":[82],"inflammatory":[84,304],"parameters":[85,305],"MS":[89,102,142,272],"without":[90],"T2DM.":[93],"Methods":[94],"All":[95],"enrolled":[97],"this":[99],"(N=62;":[103],"M.31/F.31)":[104],"MS-T2DM":[106],"(N=60;":[107],"M.30/F.30)":[108],"were":[109,146,189,214,253],"submitted":[110],"4":[112],"weeks":[113],"period":[114,135],"isocaloric":[116],"diet":[117],"pharmacological":[119],"wash-out":[120],"before":[121],"entry.":[123],"Duration":[124],"time":[125],"was":[129,257],"40":[130],"weeks.":[131],"After":[132],"8-week":[134],"treatment,":[138],"both":[139,192],"T2DM-MS":[145,274],"randomized":[147],"two":[149],"groups:":[150],"group":[151,161],"A":[152],"switching":[153,163],"(24-week)":[154,164],"from":[155,165],"ATV":[156,168,220,243,278],"alone":[157,244],"ATV/PUFA":[159,166,217,223,249,255],"B":[162],"alone.":[169,221],"Results":[170],"Significant":[171,246],"(p<0.001)":[172,213],"reductions":[173,247,284],"non-high":[179],"density":[180],"(non-HDL-C),":[183],"total":[184],"(TC)":[186],"apo-B":[188],"achieved":[190],"during":[191,216,248],"treatments":[193],"compared":[195,241],"baseline.":[197],"Moreover":[198],"significant":[199,206,226],"lowering":[200],"effects":[201,208,317],"(p<0.01)":[204,239,252],"increasing":[207],"HDL-C":[210,292],"Apo-A1":[212],"treatment":[218,224,256,276],"than":[219],"The":[222,299],"induced":[225],"improvements":[227],"fibrinogen,":[229],"factor":[230],"VII":[231],"(p<0.01),":[232],"PAI-1":[233],"(p<0.001),":[234],"blood":[235],"plasma":[237],"viscosity":[238],"results.":[245],"CRP":[251],"observed.":[254],"generally":[258],"well-tolerated,":[259],"a":[261],"safety":[262],"profile":[263,311],"laboratory":[265],"parameters.":[266],"Conclusions":[267],"In":[268],"these":[269],"combined":[275],"plus":[279],"provided":[282],"strong":[283],"LDL-C":[286],"TG":[288],"increase":[290],"evident":[294],"improvement":[295,300],"profile.":[298],"haemorheology":[302],"together":[306],"towards":[307],"antiatherogenic":[309],"lipid":[310],"expected":[313],"favourable":[316],"reducing":[319],"risk.":[321]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}